Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| Bain Capital Life Sciences IV General Partner, LLC | 4 | 13 Jan 2025 |
| Golden Matrix Group, Inc. | FORM 4 | 13 Jan 2025 |
| PULSE BIOSCIENCES, INC. | FORM 4 | 13 Jan 2025 |
| Vistagen Therapeutics, Inc. | 4 | 13 Jan 2025 |
| Vistagen Therapeutics, Inc. | 4 | 13 Jan 2025 |
| RECURSION PHARMACEUTICALS, INC. | FORM 4 | 13 Jan 2025 |
| Fidelity National Financial, Inc. | PRIMARY DOCUMENT | 13 Jan 2025 |
| UNITED THERAPEUTICS Corp | PRIMARY DOCUMENT | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| LINDSAY CORP | 4 | 13 Jan 2025 |
| Rafael Holdings, Inc. | FORM 4 | 13 Jan 2025 |
| Mission Produce, Inc. | FORM 4 | 13 Jan 2025 |
| Cyclo Therapeutics, Inc. | FORM 4 | 13 Jan 2025 |
| Akari Therapeutics Plc | 4 | 13 Jan 2025 |
| Akari Therapeutics Plc | 4 | 13 Jan 2025 |
